Develops and optimizes bioengineering platforms to produce new commercial products focused on the early detection and prevention of metabolic disorders associated with obesity.

What does this unit do?

1. Bioengineering of processes to identify and produce bioactives.
2. Development of medical devices for early detection and monitoring.
3. Engineering of delivery systems and detection of molecules.
4. Generation of clinical interventions that positively impact society.

Products and services developed by the unit

• Selection of novel biomolecules associated with metabolic diseases.
• Medical devices (based on new technologies, user-friendly and accessible) for the early detection and monitoring of metabolic diseases.
• Real-time detection sensors of biomarkers associated with metabolic diseases.
• Improvement of the performance of existing platforms for the early detection and monitoring of metabolic diseases.
• Prevention and treatment strategies for metabolic diseases and their complications.
• Strategies for the prediction and monitoring of risk of metabolic diseases.

Dr. Omar Lozano García
Unit leader. Research Professor

Design of advanced materials for drug delivery systems and probes, preclinical studies, nanosafety, nano-bio-interactions.
Get to know his work

Dr. Marco Antonio Rito Palomares
Director of the Institute for Obesity Research

Development of early detection technologies, drug delivery systems and strategies based on aqueous two-phase systems.
Get to know his work

Dr. Jorge Alejandro Benavides Lozano
Research Professor

Bioengineering, Bioprocesses, Bioproduct formulation, Bioactive discovery and characterization, Synthetic biology.
Get to know his work

Dr. Karla Patricia Mayolo Deloisa
Research Professor

Specialist in nanoparticle formulation, protein modification and bioprocesses.
Get to know her work

Dr. Mirna Alejandra González González
Research Professor

Development of flexible bioengineering platforms for biomedical applications.
Get to know her work

Develops and optimizes bioengineering platforms to produce new commercial products focused on the early detection and prevention of metabolic disorders associated with obesity.

What does this unit do?

1. Bioengineering of processes to identify and produce bioactives.
2. Development of medical devices for early detection and monitoring.
3. Engineering of delivery systems and detection of molecules.
4. Generation of clinical interventions that positively impact society.

Products and services developed by the unit

• Selection of novel biomolecules associated with metabolic diseases.
• Medical devices (based on new technologies, user-friendly and accessible) for the early detection and monitoring of metabolic diseases.
• Real-time detection sensors of biomarkers associated with metabolic diseases.
• Improvement of the performance of existing platforms for the early detection and monitoring of metabolic diseases.
• Prevention and treatment strategies for metabolic diseases and their complications.
• Strategies for the prediction and monitoring of risk of metabolic diseases.

Dr. Omar Lozano García
Unit leader. Research Professor

Design of advanced materials for drug delivery systems and probes, preclinical studies, nanosafety, nano-bio-interactions.
Get to know his work

Dr. Marco Antonio Rito Palomares
Director of the Institute for Obesity Research

Development of early detection technologies, drug delivery systems and strategies based on aqueous two-phase systems.
Get to know his work

Dr. Jorge Alejandro Benavides Lozano
Research Professor

Bioengineering, Bioprocesses, Bioproduct formulation, Bioactive discovery and characterization, Synthetic biology.
Get to know his work

Dr. Karla Patricia Mayolo Deloisa
Research Professor

Specialist in nanoparticle formulation, protein modification and bioprocesses.
Get to know her work

Dr. Mirna Alejandra González González
Research Professor

Development of flexible bioengineering platforms for biomedical applications.
Get to know her work

Diagnosing, preventing, and treating metabolic diseases and obesity by integrating a large, diverse amount of experimental data on individuals, populations, and their environments.

What does this unit do?

The great challenge of this unit is to understand the factors and integrate them for a global and deep comprehension of diseases. Managing massive data and translating it into scientific knowledge is the challenge undertaken in this unit, with the vision of translating it into new diagnoses, therapies, and preventive elements that reduce the rates of obesity and other metabolic diseases in the Mexican and Latin American populations.

Obesity: a multifactorial problem

Mexicans have aggravated obesity and metabolic disorders leading to much lower life expectancies than those in developed countries. The characteristics of these disorders remain not fully understood in our population. Genetic, epigenetic, dietary, environmental, and lifestyle factors affect the development of metabolic diseases and their prognoses.

Integrative biology

Types of research

• Genomic and metabolomic characteristics of Mexicans (population and families) with metabolic disorders contrasted with those in the same environment remaining healthy.
• Multiomic effects of the usual diet, sensory preferences, and new foods of the Mexican and Latin American populations with approaches to pregnancy and early childhood.
• Generation of data science and artificial intelligence (AI) elements to support and justify the design of new diagnoses, therapies, and public policies to combat metabolic diseases.
• Vitamin dietary interventions and functional fats from childhood and their effects on improving comorbidities related to obesity and metabolic diseases in adults.

Dr. Rocío Isabel Díaz de la Garza
Unit leader. Research Professor

Interkingdom Vitamin Functional Genomics.
More about her work

Dr. José Manuel Villalobos Escobedo
Research Professor

Functional Genomics for Bioprospecting.
More about his work

Dr. Carmen Hernández Brenes
Research Professor

Applied Metabolomics for Better Food and Health.
More about her work

Dr. Carlos Rodríguez López
Research Professor

Dietary chemical diversity and metabolomics.
More about his work

Dr. Juan Emmanuel Martínez Ledesma
Research Professor

Genomics Data Analysis and Machine Learning for Medicine.
More about his work

Diagnosing, preventing, and treating metabolic diseases and obesity by integrating a large, diverse amount of experimental data on individuals, populations, and their environments.

What does this unit do?

The great challenge of this unit is to understand the factors and integrate them for a global and deep comprehension of diseases. Managing massive data and translating it into scientific knowledge is the challenge undertaken in this unit, with the vision of translating it into new diagnoses, therapies, and preventive elements that reduce the rates of obesity and other metabolic diseases in the Mexican and Latin American populations.

Obesity: a multifactorial problem

Mexicans have aggravated obesity and metabolic disorders leading to much lower life expectancies than those in developed countries. The characteristics of these disorders remain not fully understood in our population. Genetic, epigenetic, dietary, environmental, and lifestyle factors affect the development of metabolic diseases and their prognoses.

Integrative biology

Types of research

• Genomic and metabolomic characteristics of Mexicans (population and families) with metabolic disorders contrasted with those in the same environment remaining healthy.
• Multiomic effects of the usual diet, sensory preferences, and new foods of the Mexican and Latin American populations with approaches to pregnancy and early childhood.
• Generation of data science and artificial intelligence (AI) elements to support and justify the design of new diagnoses, therapies, and public policies to combat metabolic diseases.
• Vitamin dietary interventions and functional fats from childhood and their effects on improving comorbidities related to obesity and metabolic diseases in adults.

Dr. Rocío Isabel Díaz de la Garza
Unit leader. Research Professor

Interkingdom Vitamin Functional Genomics.
More about her work

Dr. José Manuel Villalobos Escobedo
Research Professor

Functional Genomics for Bioprospecting.
More about his work

Dr. Carmen Hernández Brenes
Research Professor

Applied Metabolomics for Better Food and Health.
More about her work

Dr. Carlos Rodríguez López
Research Professor

Dietary chemical diversity and metabolomics.
More about his work

Dr. Juan Emmanuel Martínez Ledesma
Research Professor

Genomics Data Analysis and Machine Learning for Medicine.
More about his work